Cooperative Agreement NU52PS910233

Award Date 9/30/22
Completion Date 9/29/27
Dollars Obligated $32M
Funding Federal Agency
National Center for HIV/AIDS
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.136
Assistance Type
Cooperative Agreement
Place of Performance
Washington, DC, USA
Similar Awards
This Cooperative Agreement award of $2,400,000, provided by the Centers for Disease Control and Prevention's (CDC) Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136), supports the National Alliance of State & Territorial AIDS Directors (NASTAD) in establishing a Syndemic Technical Assistance Center (SYNTAC). The SYNTAC will provide capacity building assistance to strengthen the infectious disease public health workforce's ability to respond to the...
This Project Grant award, totaling $2,150,000, was provided by the Health Resources and Services Administration (HRSA) under the HIV Emergency Relief Project Grants program (CFDA 93.914). The National Alliance of State & Territorial AIDS Directors (NASTAD), a non-profit organization based in Washington, DC, will use the funding to support HRSA and its HRSA-25-063 recipients in response to HRSA-25-065: Ending the HIV Epidemic: A Plan for America - Systems Coordination Provider (EHE SCP)....
This Project Grant award of $1,334,540 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports a study to optimize the delivery of pre-exposure prophylaxis (PrEP) care for underserved rural people who inject drugs (PWID) in Kentucky. The study will deploy stepped-care adaptive interventions across three rural syringe service programs (SSPs) to identify optimal intervention pathways for increasing PrEP initiation and persistence. Key...
The Health Resources and Services Administration (HRSA) awarded a $5,600,000 Project Grant under the Special Projects of National Significance (SPNS) program to JSI Research & Training Institute Inc. The grant aims to increase access to care for people with HIV by promoting efficiencies in Ryan White HIV/AIDS Program (RWHAP) eligibility and confirmation across all RWHAP parts. JSI will: Conduct a systems assessment to identify current administrative systems, technologies, and tools for...
This $2,400,000 Cooperative Agreement awarded by the National Center for HIV/AIDS under the HIV Prevention Activities Health Department Based program (CFDA 93.940) will support and scale up HIV prevention services at Public Health - Seattle & King County's Sexual Health Clinic. The funding will strengthen the clinic's infrastructure and improve service delivery to address the syndemic of HIV and other sexually transmitted infections, with a focus on two priority populations: men who have sex...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), is intended to develop and pilot a telehealth intervention delivered through syringe service programs (SSPs) to improve uptake and retention of pre-exposure prophylaxis (PrEP) and medications for opioid use disorder (MOUD) among racially and regionally diverse people who inject drugs (PWID) in Minnesota. The $239,148 award, with a project period...
The National Institute on Drug Abuse (NIDA) awarded a $873,784 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Arizona State University to develop and pilot-test "Project Vuselela", an intervention integrating peer navigation and family engagement to improve antiretroviral therapy (ART) adherence and opioid substitution therapy (OST) continuation among people who inject drugs in South Africa. The project aims to assemble evidence-based practices,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,519,496 to Chestnut Health Systems Inc. to develop and evaluate the "PATH" (Peer Advanced Training in Harm Reduction) workforce intervention. PATH aims to reduce burnout among peer recovery support specialists (PRSS) who deliver harm reduction services, and secondarily improve service quality and system-level outcomes. The intervention...
The Southwest Center Ways to Scale Up Prevention (SWC WSUP) project is a $2,400,000 Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The project will provide affirming, stigma- and discrimination-free HIV and STI prevention and linkage to care services for four priority populations and three groups of interest disproportionately impacted by the HIV/STI syndemic in Maricopa...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,332,500 to the University of Washington to build a learning health system across Washington's state prisons. The project aims to: Establish the foundation for a learning health system, including quality metrics and a patient advisory board. Define gaps in access to care for conditions like HIV, hepatitis C, and substance use disorders by...

STRENGTHENING SYRINGE SERVICES PROGRAM - NASTAD INTENDS TO BUILD THE CAPACITY OF THE INFECTIOUS DISEASE WORKFORCE, IN PARTNERSHIP WITH SYRINGE SERVICES PROGRAMS (SSPS), TO CREATE AND EXPAND ESSENTIAL HEALTH SERVICES FOR PEOPLE WHO USE AND INJECT DRUGS (PWUDS, PWIDS). NASTAD AND PROPOSED PARTNERS VOCAL AND UNIVERSITY OF WASHINGTON (UW) ARE AMONG THE NATION'S MOST EXPERIENCED, EFFECTIVE, AND TRUSTED PROVIDERS OF DRUG USER HEALTH-FOCUSED CAPACITY BUILDING ASSISTANCE TO HEALTH DEPARTMENTS (HDS) AND COMMUNITY-BASED ORGANIZATIONS (CBOS), SPECIALIZING IN THE DEVELOPMENT, FUNDING, AND OPERATION OF SSPS AND DISSEMINATION OF PROGRAMMATIC BEST PRACTICES. SSPS ARE VITAL, FRONTLINE PUBLIC HEALTH LIFELINES FOR PEOPLE FACING HEALTH RISKS, MARGINALIZATION, AND CRIMINALIZATION RELATED TO DRUG USE AND PROVIDE ACCESS TO, AND DISPOSAL OF, STERILE SYRINGES AND INJECTION EQUIPMENT, VACCINATION, TESTING FOR INFECTIOUS DISEASES, NALOXONE DISTRIBUTION, AND LINKAGE TO INFECTIOUS DISEASE CARE AND SUBSTANCE USE TREATMENT. SERVICE CONTINUITY AND CONSISTENCY ARE ESSENTIAL TO PREVENTING INFECTIOUS DISEASE AND OVERDOSE DEATHS AMONG PEOPLE WHO USE DRUGS. DUE TO INCREASING MORBIDITY AND MORTALITY FROM UNSAFE DRUG USE AND HIGH DEMAND FOR SERVICES, NEARLY ALL EXISTING PROGRAMS ARE IN NEED OF DEDICATED AND SUSTAINABLE FUNDING. FURTHER, RESOURCES AND TAILORED SUPPORT ARE NECESSARY TO IMPROVE SERVICE AVAILABILITY THROUGH THE CREATION OF NEW PROGRAMS.

Posted 7/26/22, 12:00 AM